Design and synthesis of new esters of terpenoid alcohols as 15-lipoxygenase inhibitors

Document Type: Original Article

Authors

1 Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran

3 Department of Chemistry, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran

Abstract

Objective(s): 15-Lipoxygenases are one of the iron-containing proteins capable of performing peroxidation of unsaturated fatty acids in animals and plants. The critical role of enzymes in the formation of inflammations, sensitivities, and some cancers has been demonstrated in mammals. The importance of enzymes has led to the development of mechanistic studies, product analysis, and synthesis of inhibitors.
Materials and Methods: The inhibitory activity of all synthetic compounds against SLO (soybean 15-lipoxygenase: L1; EC 1,13,11,12) was determined using the peroxide formation method. In this method, the basis of evaluation of lipoxygenase activity is measuring the concentration of fatty acid peroxide. All measurements were compared with  4-​methyl-​2-​(4-​methylpiperazinyl)pyrimido[4,​5-​b]benzothiazine (4-MMPB) as one of the known lipoxygenase inhibitors. The radical scavenging ability of all synthetic compounds using stable free radicals (DPPH: 2,2-diphenyl-1-picrylhydrazyl) was measured for further investigation.
Results: In this study, a series of esters from phenolic acids with terpenoid alcohols was synthesized and their inhibitory potency against soybean 15-lipoxygenase and their free radical scavenging properties were determined. Among the synthetic compounds, adamantyl protocatetuate 2j and bornyl protocatetuate 2o showed the most potent inhibitory activity with IC50 values of 0.95 and 0.78 μm, respectively.
Conclusion: By changing the alcohol and acyl portions of stylosin, it was found that electronic properties play main role in lipoxygenase inhibition potency in contrast with steric features. Insertion of more reductive phenolic moiety such as catechuate and gallate lead to more lipoxygenase inhibition potency of the esters as observed in their radical scavenging activity.

Keywords

Main Subjects


1. Haeggström JZ, Funk CD.  Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease. Chem Rev 2011; 111: 5866-5898.
2. Schewe T. 15-lipoxygenase-1: a prooxidant enzyme. Biol Chem 200; 2383: 365-374.
3. Ding XZ, Iversen P, Cluck MW, Knezetic JA, Adrian TE. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Comm 1999; 261: 218-223.
4. Kelavkar UP, Glasgow W, Eling TE. The Effect of 15-Lipoxygenase-1 Expression on Cancer Cells Curr Urol Rep 2002; 3: 207-214.
5. Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, et al.  DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Prostaglandins Other Lipid Mediat 2007; 82:185–197.
6. Reddy N, Everhart A, Eling T, Glasgow W. Characterization of a 15-lipoxygenase in human breast carcinoma: BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF. Biochem Biophys Res Comm 1997; 231:111–116.
7. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, et al. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptordeficient mice. Arteriosler Thromb Vasc Biol 2000; 20:2100-2105.
8. Sultana C, Shen Y, Rattan V, Kalra VJ. Lipoxygenase metabolites induced expression of adhesion molecules and transendo the lial migration of monocyte-like HL-60 cells is linked to protein kinase C activation. J Cell Phys 1996;167: 467-487.
9. Charlier C, Michaux C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) As a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem 2003; 38: 645-659.
10.    Kohyama N, Nagata T, Fujimoto S, Sekiya K. Inhibition of Arachidonate Lipoxygenase Activities by 2-(3,4-Dihydroxyphenyl) ethanol, a Phenolic Compound from Olives. Biosci Biotechnol Biochem 1997; 61:347-350.
11.    Pontiki E, Hadjipavlou-Litina D, Litinas K, Geromichalos G. Novel Cinnamic Acid Derivatives as Antioxidant and Anticancer Agents: Design, Synthesis and Modeling Studies. Molecules 2014;19: 9655-9674.
12. Saidkhodzhaev AI, Nikonov GK. Components of the roots of Ferula ovina. Chem Nat Comp 1974;10: 539-540.
13. Nikpour M, Mousavian M, Davoodnejad M, Alimardani M, Sadeghian H. Synthesis of new series of pyrimido[4,5-b][1,4] benzothiazines as 15-lipoxygenase inhibitors and study of their inhibitory mechanism. Med Chem. Res 2016; 22: 5036-5043.
14. Jabbari A, Davoodnejad M, Alimardani M, Assadieskandar A, Sadeghian A, Safdari H, et al. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors. Bioorg Med Chem 2012; 20: 5518-5526.
15. Yang LX, Huang KX, Li HB, Gong JX, Wang F, Feng YB, et al. Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives. J Med Chem 2009; 52:7732-7752.
16. Ha TJ, Shimizu K, Kubo I. Lipoxygenase inhibitory activity of alkyl protocatechuates. Food Chemistry 2014; 159:471-476.
17. Seyedi SM, Eshghi H, Jafari Z, Attaran N, Sadeghian H, Saberi MR, et al. Design, synthesis and SAR studies of 4-allyoxyaniline amides as potent 15-lipoxygensae inhibitors. Bioorg Med Chem 2009; 17:1614-1622.
18. Kubo I, Fujita K, Nihei K. Molecular Design of Multifunctional Antibacterial Agents Against Methicillin Resistant Staphylococcus aureus (MRSA). Bioorg Med Chem 2003; 11:4255-4262.
19. Sahranavard S, Naghibi F, Mosaddegh M, Esmaeili S, Sarkhail P, Taghvaei M, et al. Cytotoxic activities of selected medicinal plants from Iran and phytochemical evaluation of the most potent extract. Res Pharm Sci 2009; 4:133-137.
20. LeBlanc LM, Paré AF, Jean-François J, Hébert MJG, Surette ME, Touaibia M. Synthesis and Antiradical/Antioxidant Activities of Caffeic Acid Phenethyl Ester and Its Related Propionic, Acetic, and Benzoic Acid Analogues.  Molecules 2012; 17:14637-14650.
21. Rajendran N, Subramaniam S, Charan Raja MR, Venkata Subbarao HM, Venkata subramanian U, Pemaiah B, et al. Design, synthesis and in-vitro anti-leukemic evaluation of ferulic acid analogues as Bcr-Abl inhibitors. RSC Adv 2016; 6:70480-70484.
22. Chen H, Chen Y, Lv Y, Zeng F, Zhang J, Zhou Y, et al. Synthesis and antitumor activity of feruloyl and caffeoyl derivatives. Bioorg Med Chem Lett 2014; 24:4349-4608.  
23. Chochkova MG, Georgieva AP, Ivanova GI, Nikolova N, Mukova L, Nikolaeva-Glomb L, et al. Synthesis and biological activity of hydroxycinnamoylcontaining antiviral drugs. J Serb Chem Soc 2014; 79:517–526.